InflaRx (IFRX) Cash Flow: Operating & Free Cash Flow

InflaRx Cash Flow Statement Analysis

Values in millions EUR

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for InflaRx N.V. (IFRX) - Annual data in millions EUR
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Mar 2020	Dec 2018	Dec 2017
Operating Activities
Net Income	-43.83	-46.06	-42.67	-29.48	-45.63	-33.98	-53.25	-29.82	-24.24
Depreciation & Amortization	0.40	0.49	0.57	0.60	0.67	0.71	0.66	0.17	0.07
Deferred Income Tax	0.00	0.00	0.00	0.00	1.16	0.93	0.00	-1.88	0.07
Stock Based Compensation	0.00	4.07	3.41	6.04	4.33	1.12	6.83	12.09	4.55
Change in Working Capital	4.66	-2.28	1.00	-9.77	1.54	-5.35	-2.34	1.83	2.58
Change in Accounts Receivable	2.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Change in Inventory	6.63	4.47	-11.37	0.00	0.00	0.00	0.00	0.00	0.00
Change in Accounts Payable	-5.76	0.00	0.00	-3.59	0.32	-4.16	0.00	2.19	3.09
Change in Other Working Capital	1.68	-6.75	12.37	-4.88	1.22	-1.19	-2.34	-0.36	-0.50
Other Operating Activities	4.84	-4.76	-0.13	-2.37	-2.00	0.97	4.89	-6.11	4.82
Net Cash from Operating Activities	-33.92	-48.56	-37.81	-33.74	-39.94	-36.53	-43.20	-23.71	-12.15
Investing Activities
Capital Expenditures	-0.11	-0.05	-0.08	-0.16	-0.04	-0.09	-0.59	-0.81	-0.15
Acquisitions	0.00	0.00	0.00	-19.52	0.04	0.09	0.00	0.81	0.00
Purchases of Investments	-44.28	-35.34	-104.05	-64.47	-97.52	21.46	0.00	-106.66	-0.02
Sales/Maturities of Investments	47.50	87.75	86.44	84.00	71.60	123.06	0.00	8.01	0.00
Other Investing Activities	0.00	0.00	0.00	19.52	-0.04	-0.09	20.94	-0.81	0.00
Net Cash from Investing Activities	3.11	52.36	-17.70	19.36	-25.95	21.36	20.34	-99.45	-0.17
Financing Activities
Debt Repayment	-0.36	-0.39	-0.37	-0.36	-0.36	-0.37	-0.30	0.00	0.00
Common Stock Issued	32.35	1.10	56.48	2.30	65.14	10.27	0.00	52.99	90.90
Other Financing Activities	0.01	-0.32	-3.12	-0.05	-3.20	-0.73	0.00	-3.35	17.90
Net Cash from Financing Activities	32.00	0.39	52.99	1.94	61.58	9.17	-0.29	49.64	108.80
Summary
Effect of Forex Changes on Cash	-1.37	1.41	-0.97	2.46	4.59	-1.17	0.90	5.63	-2.32
Net Change in Cash	-0.18	5.61	-3.50	-9.98	0.28	-7.16	-22.25	-67.90	94.17
Cash at Beginning of Period	16.20	12.77	16.27	26.25	25.97	33.13	55.39	123.28	29.12
Cash at End of Period	16.02	18.38	12.77	16.27	26.25	25.97	33.13	55.39	123.28
Free Cash Flow	-34.03	-48.60	-37.89	-33.91	-39.97	-36.62	-43.80	-24.52	-12.30
Supplemental Disclosures
Interest Paid	-	0.02	0.04	0.04	0.02	0.03	-	-	-

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About InflaRx Cash Flow

What is InflaRx's free cash flow?

InflaRx had negative free cash flow of EUR 34.03M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −EUR 33.92M minus EUR 111.13K of capital expenditures.

How much does InflaRx spend on capital expenditures?

InflaRx spent EUR 111.13K on capital expenditures in fiscal 2025, compared with EUR 46.87K a year earlier.

Does InflaRx pay dividends or buy back shares?

InflaRx's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition